Apable, Juvilyn S.
HRN: 11-99-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/24/2022
06/30/2022
IVTT
500mg
Q8h
Ameobiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes